CasNo.1190307-88-0,High quality Sofosbuvir powder,(1190307-88-0) Suppliers

1 Gram	Negotiable

Min.Order :1 Gram
Purity: 99%min
Payment Terms : T/T,Other

Keywords

Sofosbuvir Sofosbuvir price Sofosbuvir powder

Quick Details

Appearance:A white or almost white crystalline powder
Application:treatment of chronic hepatitis C
PackAge:bag/tin/drum
ProductionCapacity:1000|Kilogram|Month
Storage:Store under room temperature
Transportation:EMS or Sea transportation

Superiority:

Competive advantages

1.Rich experience

We specialize in this filed for many years,our steriods and hormones exported to all over the world and established long friendly relations of coroperation with them.

2.Great quality,purity and favorable

Good quality is one of our biggest secert to success;u can get the best quality and service from us.

3.Safest and fastest delivery

We have adequate stock so that we can deliver the products with 24 hours as soon as receiving the payment.Fast and discreet shipment will be arranged to pass customs.

4.Good package

Unique ways to ship 10g to 100kg powders to your destination.We offer melting powder into liquid service and ship the liquid in special bottles.

5.Great after-sales service

Any questions or problems after receiving the product,pls feel free to contact us.Problems would be solved immediately.

General Comments:

We have professional team for package and shipment.Unique ways to ship 10g to 100kg powders at one time to your country.Our shipments are by EMS,DHL,TNT,FEDEX,HKEMS,UPS,etc for 25kg,between 25kg-200kg by air,over 200kg by sea.Fast and secure shipment could be arranged for customs pass guaranteed.

Our company has independent import and export authority,also has the certificate of importing and exporting pharmaceutical materials.At the same time we are developed manufactures with mass stock.

Details:

Sofosbuvir is used for the treatment of chronic hepatitis C, genotypes 1, 2, 3, and 4, in combination with pegylated interferon and ribavirin, or with ribavirin alone. It is also used in combination with the viral NS5a inhibitor ledipasvir in an interferon-free combination for the treatment of genotype 1 hepatitis C infection. Sofosbuvir is also used in HCV patients with an HIV coinfection. The treatment is based on a number of clinical trials, for example the ELECTRON trial which showed that a dual interferon-free regimen of sofosbuvir plus ribavirin produced a 24-week post-treatment sustained virological response (SVR24) rate of 100% for previously untreated patients with HCV genotypes 2 or 3.

In early 2014, the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America jointly published a recommendation for the management of hepatitis C. In this recommendation, sofosbuvir and ribavirin, with or without pegylated interferon, are part of all first-line treatments for HCV genotypes 1 to 6, and are also part of some second-line treatments.